Posted inHealth
FDA Evaluates Compounding Status of Popular Peptides Amid Growing Demand
Federal health regulators are currently evaluating whether to permit compounding pharmacies to manufacture specific therapeutic peptides, including BPC-157 and TB-500, which were previously restricted from production. The United States Food…
